Defiance Daily Target 2X Long LLY ETF Short Interest Drops 67.8% in January

The leveraged ETF tracking Eli Lilly saw a significant decline in short positions last month.

Published on Feb. 11, 2026

Got story updates? Submit your updates here. ›

The Defiance Daily Target 2X Long LLY ETF (NYSEARCA:LLYX) saw a 67.8% decrease in short interest during January, with the number of shares sold short dropping from 146,057 on January 15th to 47,102 on January 30th. This represents approximately 2.8% of the ETF's total shares outstanding.

Why it matters

The drop in short interest suggests investors are less bearish on the Eli Lilly-tracking ETF, which provides 2x leveraged exposure to the pharmaceutical company's stock price movements. This could signal growing optimism around Eli Lilly's business and future performance.

The details

Defiance Daily Target 2X Long LLY ETF is an exchange-traded fund that seeks to provide 2x leveraged exposure to the daily share price movement of Eli Lilly and Company (NYSE: LLY). The fund was launched in August 2024. As of January 30th, the short interest ratio was 0.1 days, meaning it would take less than a day for short sellers to cover their positions based on the ETF's average daily trading volume.

  • The short interest data is as of January 30th, 2026.
  • The ETF was launched on August 7, 2024.

The players

Defiance Daily Target 2X Long LLY ETF

An exchange-traded fund that provides 2x leveraged exposure to the daily share price movement of Eli Lilly and Company.

Eli Lilly and Company

A major pharmaceutical company whose stock the Defiance Daily Target 2X Long LLY ETF tracks.

Got photos? Submit your photos here. ›

The takeaway

The significant decline in short interest for the Defiance Daily Target 2X Long LLY ETF suggests growing investor optimism around Eli Lilly's prospects, as evidenced by reduced bearish bets on the leveraged fund tracking the pharmaceutical company's stock price.